Related references
Note: Only part of the references are listed.Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia
Elena Perez-Nadales et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients
B. Gutierrez-Gutierrez et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Optimizing therapy of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae
Carlota Gudiol et al.
CURRENT OPINION IN CRITICAL CARE (2019)
Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
J. M. Aguado et al.
TRANSPLANTATION REVIEWS (2018)
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial
Patrick N. A. Harris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis
Michail Alevizakos et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Belen Gutierrez-Gutierrez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk Evaluation
Scott R. Evans et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2016)
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
Scott R. Evans et al.
CLINICAL INFECTIOUS DISEASES (2015)
Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections
Jian Zhou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Global antibiotic consumption 2000 to 2010: an analysis of Cross Mark 742 national pharmaceutical sales data
Thomas P. Van Boeckel et al.
LANCET INFECTIOUS DISEASES (2014)
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
Dolores Sousa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Vicki L. Collins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Chi-Chang Huang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence
David P. Nicolau et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis
Un-In Wu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort
E. Vidal et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy
Alexandre P. Zavascki et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement Guidelines for Reporting Observational Studies
Erik von Elm et al.
EPIDEMIOLOGY (2007)
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
MM Levy et al.
CRITICAL CARE MEDICINE (2003)
Share Paper
